Radiofrequency ablation +/- irbesartan in patients with long-lasting persistent atrial fibrillation

Trial Profile

Radiofrequency ablation +/- irbesartan in patients with long-lasting persistent atrial fibrillation

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Apr 2011

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Apr 2011 New trial record
    • 01 Apr 2011 Results published in the Annals of Thoracic Surgery.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top